Skip to Content

Applied Molecular Transport Inc.

Merger

  • Date:
  • 9/21/2023
  • Company Name:
  • Applied Molecular Transport Inc.
  • Stock Symbol:
  • AMTI
  • Company Name - Buyer:
  • Cyclo Therapeutics, Inc.
  • Stock Symbol - Buyer:
  • CYTH
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 9/21/2023

Case Finder

Locate any case using the tools below.

NEW YORK, September 21, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Applied Molecular Transport Inc. (NASDAQ: AMTI) (“AMT”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Cyclo Therapeutics, Inc. (NASDAQ: CYTH) (“Cyclo Therapeutics”).

On September 21, 2023, AMT announced that it had entered into an agreement to be acquired by Cyclo Therapeutics in an all-stock deal. Pursuant to the merger agreement, AMT stockholders will receive approximately 0.174 shares of Cyclo Therapeutics in exchange for each of their shares in AMT. Cyclo Therapeutics expects to issue approximately 7.624 million shares of Cyclo Therapeutics’ common stock to AMT shareholders, equating to approximately 25% of the combined company on a fully diluted basis. The deal is expected to close by the fourth quarter of 2023.

Bragar Eagel & Squire is concerned that AMT's board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for AMT's stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Applied Molecular Transport Inc.. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: